ブルトン型チロシンキナーゼ（BTK）阻害剤のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Insights and Forecast to 2028

• レポートコード：QY2203B05670
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、88ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のブルトン型チロシンキナーゼ（BTK）阻害剤の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にブルトン型チロシンキナーゼ（BTK）阻害剤の世界市場のxxx％を占める「第一世代」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「白血病」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のブルトン型チロシンキナーゼ（BTK）阻害剤の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのブルトン型チロシンキナーゼ（BTK）阻害剤市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのブルトン型チロシンキナーゼ（BTK）阻害剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ブルトン型チロシンキナーゼ（BTK）阻害剤のグローバル主要メーカーには、Johnson & Johnson and AbbVie (Imbruvica)、AstraZeneca (Calquence)、BeiGene (Zanubrutinib)、InnoCare (Orelabrutinib)、Merckなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ブルトン型チロシンキナーゼ（BTK）阻害剤市場は、種類と用途によって区分されます。世界のブルトン型チロシンキナーゼ（BTK）阻害剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
第一世代、第二世代

【用途別セグメント】
白血病、リンパ腫、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ブルトン型チロシンキナーゼ（BTK）阻害剤製品概要
- 種類別市場（第一世代、第二世代）
- 用途別市場（白血病、リンパ腫、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のブルトン型チロシンキナーゼ（BTK）阻害剤販売量予測2017-2028
- 世界のブルトン型チロシンキナーゼ（BTK）阻害剤売上予測2017-2028
- ブルトン型チロシンキナーゼ（BTK）阻害剤の地域別販売量
- ブルトン型チロシンキナーゼ（BTK）阻害剤の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ブルトン型チロシンキナーゼ（BTK）阻害剤販売量
- 主要メーカー別ブルトン型チロシンキナーゼ（BTK）阻害剤売上
- 主要メーカー別ブルトン型チロシンキナーゼ（BTK）阻害剤価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（第一世代、第二世代）
- ブルトン型チロシンキナーゼ（BTK）阻害剤の種類別販売量
- ブルトン型チロシンキナーゼ（BTK）阻害剤の種類別売上
- ブルトン型チロシンキナーゼ（BTK）阻害剤の種類別価格
・用途別市場規模（白血病、リンパ腫、その他）
- ブルトン型チロシンキナーゼ（BTK）阻害剤の用途別販売量
- ブルトン型チロシンキナーゼ（BTK）阻害剤の用途別売上
- ブルトン型チロシンキナーゼ（BTK）阻害剤の用途別価格
・北米市場
- 北米のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（種類別、用途別）
- 主要国別のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（種類別、用途別）
- 主要国別のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（種類別、用途別）
- 主要国別のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（種類別、用途別）
- 主要国別のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（種類別、用途別）
- 主要国別のブルトン型チロシンキナーゼ（BTK）阻害剤市場規模（トルコ、サウジアラビア）
・企業情報
Johnson & Johnson and AbbVie (Imbruvica)、AstraZeneca (Calquence)、BeiGene (Zanubrutinib)、InnoCare (Orelabrutinib)、Merck
・産業チェーン及び販売チャネル分析
- ブルトン型チロシンキナーゼ（BTK）阻害剤の産業チェーン分析
- ブルトン型チロシンキナーゼ（BTK）阻害剤の原材料
- ブルトン型チロシンキナーゼ（BTK）阻害剤の生産プロセス
- ブルトン型チロシンキナーゼ（BTK）阻害剤の販売及びマーケティング
- ブルトン型チロシンキナーゼ（BTK）阻害剤の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ブルトン型チロシンキナーゼ（BTK）阻害剤の産業動向
- ブルトン型チロシンキナーゼ（BTK）阻害剤のマーケットドライバー
- ブルトン型チロシンキナーゼ（BTK）阻害剤の課題
- ブルトン型チロシンキナーゼ（BTK）阻害剤の阻害要因
・主な調査結果

BTK inhibitors are able to interfere with cell signaling cascades and prevent key phosphorylations in B cells, therefore preventing or reducing inflammation.
Market Analysis and Insights: Global Bruton Tyrosine Kinase (BTK) Inhibitors Market
Due to the COVID-19 pandemic, the global Bruton Tyrosine Kinase (BTK) Inhibitors market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, First Generation accounting for % of the Bruton Tyrosine Kinase (BTK) Inhibitors global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Leukemia segment is altered to an % CAGR throughout this forecast period.
China Bruton Tyrosine Kinase (BTK) Inhibitors market size is valued at US$ million in 2021, while the US and Europe Bruton Tyrosine Kinase (BTK) Inhibitors are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Bruton Tyrosine Kinase (BTK) Inhibitors landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Bruton Tyrosine Kinase (BTK) Inhibitors include Johnson & Johnson and AbbVie (Imbruvica), AstraZeneca (Calquence), BeiGene (Zanubrutinib), InnoCare (Orelabrutinib) and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Bruton Tyrosine Kinase (BTK) Inhibitors Scope and Segment
Bruton Tyrosine Kinase (BTK) Inhibitors market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Bruton Tyrosine Kinase (BTK) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
First Generation
Second Generation
Segment by Application
Leukemia
Lymphoma
Others
By Company
Johnson & Johnson and AbbVie (Imbruvica)
AstraZeneca (Calquence)
BeiGene (Zanubrutinib)
InnoCare (Orelabrutinib)
Merck
By Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Bruton Tyrosine Kinase (BTK) Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 First Generation
1.2.3 Second Generation
1.3 Market by Application
1.3.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Leukemia
1.3.3 Lymphoma
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Estimates and Forecasts 2017-2028
2.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Estimates and Forecasts 2017-2028
2.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Region
2.4.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Region (2017-2022)
2.4.2 Global Sales Bruton Tyrosine Kinase (BTK) Inhibitors by Region (2023-2028)
2.5 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region
2.5.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region (2017-2022)
2.5.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Manufacturers
3.1.1 Global Top Bruton Tyrosine Kinase (BTK) Inhibitors Manufacturers by Sales (2017-2022)
3.1.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bruton Tyrosine Kinase (BTK) Inhibitors in 2021
3.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Manufacturers
3.2.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Manufacturers (2017-2022)
3.2.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bruton Tyrosine Kinase (BTK) Inhibitors Revenue in 2021
3.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type
4.1.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Historical Sales by Type (2017-2022)
4.1.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Forecasted Sales by Type (2023-2028)
4.1.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2017-2028)
4.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type
4.2.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Historical Revenue by Type (2017-2022)
4.2.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2017-2028)
4.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Price by Type
4.3.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Price by Type (2017-2022)
4.3.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application
5.1.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Historical Sales by Application (2017-2022)
5.1.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Forecasted Sales by Application (2023-2028)
5.1.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2017-2028)
5.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application
5.2.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Historical Revenue by Application (2017-2022)
5.2.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application (2017-2028)
5.3 Global Bruton Tyrosine Kinase (BTK) Inhibitors Price by Application
5.3.1 Global Bruton Tyrosine Kinase (BTK) Inhibitors Price by Application (2017-2022)
5.3.2 Global Bruton Tyrosine Kinase (BTK) Inhibitors Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Type
6.1.1 North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2028)
6.1.2 North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2028)
6.2 North America Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Application
6.2.1 North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2028)
6.2.2 North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2028)
6.3 North America Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Country
6.3.1 North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2017-2028)
6.3.2 North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
7 Europe
7.1 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Type
7.1.1 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2028)
7.1.2 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2028)
7.2 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Application
7.2.1 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2028)
7.2.2 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2028)
7.3 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Country
7.3.1 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2017-2028)
7.3.2 Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Type
8.1.1 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2028)
8.1.2 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2028)
8.2 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Application
8.2.1 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2028)
8.2.2 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2028)
8.3 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Region
8.3.1 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Region (2017-2028)
8.3.2 Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Type
9.1.1 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2028)
9.1.2 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2028)
9.2 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Application
9.2.1 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2028)
9.2.2 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2028)
9.3 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Country
9.3.1 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2017-2028)
9.3.2 Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Type
10.1.1 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2028)
10.2 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Application
10.2.1 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2028)
10.3 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Market Size by Country
10.3.1 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson and AbbVie (Imbruvica)
11.1.1 Johnson & Johnson and AbbVie (Imbruvica) Corporation Information
11.1.2 Johnson & Johnson and AbbVie (Imbruvica) Overview
11.1.3 Johnson & Johnson and AbbVie (Imbruvica) Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson and AbbVie (Imbruvica) Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson and AbbVie (Imbruvica) Recent Developments
11.2 AstraZeneca (Calquence)
11.2.1 AstraZeneca (Calquence) Corporation Information
11.2.2 AstraZeneca (Calquence) Overview
11.2.3 AstraZeneca (Calquence) Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AstraZeneca (Calquence) Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AstraZeneca (Calquence) Recent Developments
11.3 BeiGene (Zanubrutinib)
11.3.1 BeiGene (Zanubrutinib) Corporation Information
11.3.2 BeiGene (Zanubrutinib) Overview
11.3.3 BeiGene (Zanubrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BeiGene (Zanubrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BeiGene (Zanubrutinib) Recent Developments
11.4 InnoCare (Orelabrutinib)
11.4.1 InnoCare (Orelabrutinib) Corporation Information
11.4.2 InnoCare (Orelabrutinib) Overview
11.4.3 InnoCare (Orelabrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 InnoCare (Orelabrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 InnoCare (Orelabrutinib) Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Overview
11.5.3 Merck Bruton Tyrosine Kinase (BTK) Inhibitors Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Merck Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bruton Tyrosine Kinase (BTK) Inhibitors Industry Chain Analysis
12.2 Bruton Tyrosine Kinase (BTK) Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bruton Tyrosine Kinase (BTK) Inhibitors Production Mode & Process
12.4 Bruton Tyrosine Kinase (BTK) Inhibitors Sales and Marketing
12.4.1 Bruton Tyrosine Kinase (BTK) Inhibitors Sales Channels
12.4.2 Bruton Tyrosine Kinase (BTK) Inhibitors Distributors
12.5 Bruton Tyrosine Kinase (BTK) Inhibitors Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bruton Tyrosine Kinase (BTK) Inhibitors Industry Trends
13.2 Bruton Tyrosine Kinase (BTK) Inhibitors Market Drivers
13.3 Bruton Tyrosine Kinase (BTK) Inhibitors Market Challenges
13.4 Bruton Tyrosine Kinase (BTK) Inhibitors Market Restraints
14 Key Findings in The Global Bruton Tyrosine Kinase (BTK) Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of First Generation
Table 3. Major Manufacturers of Second Generation
Table 4. Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Region (2017-2022) & (Kg)
Table 7. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Region (2017-2022)
Table 8. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Region (2023-2028) & (Kg)
Table 9. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Region (2023-2028)
Table 10. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Region (2017-2022)
Table 12. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Region (2023-2028)
Table 14. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Manufacturers (2017-2022) & (Kg)
Table 15. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Manufacturers (2017-2022)
Table 16. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Manufacturers (2017-2022)
Table 18. Bruton Tyrosine Kinase (BTK) Inhibitors Price by Manufacturers (2017-2022) &(USD/g)
Table 19. Global Bruton Tyrosine Kinase (BTK) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Bruton Tyrosine Kinase (BTK) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bruton Tyrosine Kinase (BTK) Inhibitors as of 2021)
Table 21. Bruton Tyrosine Kinase (BTK) Inhibitors Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Bruton Tyrosine Kinase (BTK) Inhibitors Product Offered
Table 23. Date of Manufacturers Enter into Bruton Tyrosine Kinase (BTK) Inhibitors Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 26. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2023-2028) & (Kg)
Table 27. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Type (2017-2022)
Table 28. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Type (2023-2028)
Table 29. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Type (2017-2022)
Table 32. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Type (2023-2028)
Table 33. Bruton Tyrosine Kinase (BTK) Inhibitors Price by Type (2017-2022) & (USD/g)
Table 34. Global Bruton Tyrosine Kinase (BTK) Inhibitors Price Forecast by Type (2023-2028) & (USD/g)
Table 35. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 36. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2023-2028) & (Kg)
Table 37. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Application (2017-2022)
Table 38. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Application (2023-2028)
Table 39. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Application (2017-2022)
Table 42. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Application (2023-2028)
Table 43. Bruton Tyrosine Kinase (BTK) Inhibitors Price by Application (2017-2022) & (USD/g)
Table 44. Global Bruton Tyrosine Kinase (BTK) Inhibitors Price Forecast by Application (2023-2028) & (USD/g)
Table 45. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 46. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2023-2028) & (Kg)
Table 47. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 50. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2023-2028) & (Kg)
Table 51. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 54. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2023-2028) & (Kg)
Table 55. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 58. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2023-2028) & (Kg)
Table 59. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 62. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2023-2028) & (Kg)
Table 63. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 66. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2023-2028) & (Kg)
Table 67. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 70. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2023-2028) & (Kg)
Table 71. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 74. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2023-2028) & (Kg)
Table 75. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Region (2017-2022) & (Kg)
Table 78. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Region (2023-2028) & (Kg)
Table 79. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 82. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2023-2028) & (Kg)
Table 83. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 86. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2023-2028) & (Kg)
Table 87. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 90. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2023-2028) & (Kg)
Table 91. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2017-2022) & (Kg)
Table 94. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Type (2023-2028) & (Kg)
Table 95. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2017-2022) & (Kg)
Table 98. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Application (2023-2028) & (Kg)
Table 99. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2017-2022) & (Kg)
Table 102. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales by Country (2023-2028) & (Kg)
Table 103. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue by Country (2023-2028) & (US$ Million)
Table 105. Johnson & Johnson and AbbVie (Imbruvica) Corporation Information
Table 106. Johnson & Johnson and AbbVie (Imbruvica) Description and Major Businesses
Table 107. Johnson & Johnson and AbbVie (Imbruvica) Bruton Tyrosine Kinase (BTK) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 108. Johnson & Johnson and AbbVie (Imbruvica) Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Johnson & Johnson and AbbVie (Imbruvica) Recent Developments
Table 110. AstraZeneca (Calquence) Corporation Information
Table 111. AstraZeneca (Calquence) Description and Major Businesses
Table 112. AstraZeneca (Calquence) Bruton Tyrosine Kinase (BTK) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 113. AstraZeneca (Calquence) Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. AstraZeneca (Calquence) Recent Developments
Table 115. BeiGene (Zanubrutinib) Corporation Information
Table 116. BeiGene (Zanubrutinib) Description and Major Businesses
Table 117. BeiGene (Zanubrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 118. BeiGene (Zanubrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. BeiGene (Zanubrutinib) Recent Developments
Table 120. InnoCare (Orelabrutinib) Corporation Information
Table 121. InnoCare (Orelabrutinib) Description and Major Businesses
Table 122. InnoCare (Orelabrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 123. InnoCare (Orelabrutinib) Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. InnoCare (Orelabrutinib) Recent Developments
Table 125. Merck Corporation Information
Table 126. Merck Description and Major Businesses
Table 127. Merck Bruton Tyrosine Kinase (BTK) Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 128. Merck Bruton Tyrosine Kinase (BTK) Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Merck Recent Developments
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Bruton Tyrosine Kinase (BTK) Inhibitors Distributors List
Table 133. Bruton Tyrosine Kinase (BTK) Inhibitors Customers List
Table 134. Bruton Tyrosine Kinase (BTK) Inhibitors Market Trends
Table 135. Bruton Tyrosine Kinase (BTK) Inhibitors Market Drivers
Table 136. Bruton Tyrosine Kinase (BTK) Inhibitors Market Challenges
Table 137. Bruton Tyrosine Kinase (BTK) Inhibitors Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Bruton Tyrosine Kinase (BTK) Inhibitors Product Picture
Figure 3. Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Share by Type in 2021 & 2028
Figure 3. First Generation Product Picture
Figure 4. Second Generation Product Picture
Figure 5. Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Share by Application in 2021 & 2028
Figure 6. Leukemia
Figure 7. Lymphoma
Figure 8. Others
Figure 9. Bruton Tyrosine Kinase (BTK) Inhibitors Report Years Considered
Figure 10. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales 2017-2028 (Kg)
Figure 11. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue 2017-2028 (US$ Million)
Figure 13. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Region (2017-2022)
Figure 15. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Region (2023-2028)
Figure 16. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales YoY (2017-2028) & (Kg)
Figure 17. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales YoY (2017-2028) & (Kg)
Figure 19. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales YoY (2017-2028) & (Kg)
Figure 21. Asia-Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales YoY (2017-2028) & (Kg)
Figure 23. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales YoY (2017-2028) & (Kg)
Figure 25. Middle East & Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Bruton Tyrosine Kinase (BTK) Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Bruton Tyrosine Kinase (BTK) Inhibitors in the World: Market Share by Bruton Tyrosine Kinase (BTK) Inhibitors Revenue in 2021
Figure 28. Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2017-2028)
Figure 30. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2017-2028)
Figure 31. Global Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2017-2028)
Figure 32. Global Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application (2017-2028)
Figure 33. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2017-2028)
Figure 34. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2017-2028)
Figure 35. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2017-2028)
Figure 36. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application (2017-2028)
Figure 37. North America Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Country (2017-2028)
Figure 38. North America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Country (2017-2028)
Figure 39. United States Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 41. Mexico Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2017-2028)
Figure 43. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2017-2028)
Figure 44. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2017-2028)
Figure 45. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application (2017-2028)
Figure 46. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Country (2017-2028)
Figure 47. Europe Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Country (2017-2028)
Figure 48. Germany Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 49. France Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 50. UK Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Region (2017-2028)
Figure 59. China Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 62. India Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2017-2028)
Figure 69. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2017-2028)
Figure 71. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Country (2017-2028)
Figure 73. Latin America Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Country (2017-2028)
Figure 74. Mexico Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Bruton Tyrosine Kinase (BTK) Inhibitors Revenue Share by Country (2017-2028)
Figure 83. Turkey Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Bruton Tyrosine Kinase (BTK) Inhibitors Revenue (2017-2028) & (US$ Million)
Figure 86. Bruton Tyrosine Kinase (BTK) Inhibitors Value Chain
Figure 87. Bruton Tyrosine Kinase (BTK) Inhibitors Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

以下、関連資料のご紹介

デオキシコール酸ナトリウムのグローバル市場インサイト・予測（～2028年）

Global Sodium Deoxycholate Market Insights, Forecast to 2028
QY2203B04182 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のデオキシコール酸ナトリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にデオキシコ...

N,N,N-トリメチルボラジンのグローバル市場インサイト・予測（～2028年）

Global N,N,N-Trimethylborazine Market Insights and Forecast to 2028
QY2203B00860 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のN,N,N-トリメチルボラジンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にN,N...

クラウドコンピューティングスタックレイヤーのグローバル市場インサイト・予測（～2028年）

Global Cloud Computing Stack Layers Market Insights and Forecast to 2028
QY2203B02533 2022年3月 112Pages
新型コロナウイルス感染症のパンデミックにより、世界のクラウドコンピューティングスタックレイヤーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、202...

冷凍機用ガスケットのグローバル市場インサイト・予測（～2028年）

Global Refrigerator Gasket Market Insights, Forecast to 2028
QY2203B14262 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界の冷凍機用ガスケットの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に冷凍機用ガスケット...

ヒプロメロースフタレートのグローバル市場インサイト・予測（～2028年）

Global Hypromellose Phthalate Market Insights and Forecast to 2028
QY2203B05209 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界のヒプロメロースフタレートの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヒプロメロー...

2,2′-ビス(トリフルオロメチル)ベンジジンのグローバル市場インサイト・予測（～2028年）

Global 2,2'-Bis(trifluoromethyl)benzidine Market Insights, Forecast to 2028
QY2203B00069 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界の2,2'-ビス(トリフルオロメチル)ベンジジンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2...

カルボプラチンのグローバル市場インサイト・予測（～2028年）

Global Carboplatin Market Insights and Forecast to 2028
QY2203B02393 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界のカルボプラチンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にカルボプラチンの世界市...

リチウムイオン電池材料のグローバル市場インサイト・予測（～2028年）

Global Lithium-ion Battery Materials Market Insights and Forecast to 2028
QY2203B06987 2022年3月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界のリチウムイオン電池材料の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にリチウムイオン...

ハングオーバー製品のグローバル市場インサイト・予測（～2028年）

Global Hangover Product Market Insights, Forecast to 2028
QY2203B05038 2022年3月 90Pages
新型コロナウイルス感染症のパンデミックにより、世界のハングオーバー製品の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にハングオーバー製品...

1,1′-ビ-2-ナフトールのグローバル市場インサイト・予測（～2028年）

Global 1,1'-Bi-2-naphthol Market Insights and Forecast to 2028
QY2203B00014 2022年3月 92Pages
新型コロナウイルス感染症のパンデミックにより、世界の1,1'-ビ-2-ナフトールの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に1,1'...

カルボプラチンのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Carboplatin Market Due to the COVID-19 pandemic, the global Carboplatin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic …
ハングオーバー製品のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Hangover Product Market Due to the COVID-19 pandemic, the global Hangover Product market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the…
ハイドロセラピーチェアのグローバル市場インサイト・予測（～2028年） Hydrotherapy Chairs are lower extremities can be treated easily and more comfortably with these adjustable whirlpool chairs available with or without casters. Very economical, hygienic and useful products. Market Analysis and Insights: Global Hydrotherapy Chairs Market Due to the COVID-19 pandemic, …
パスワードロックのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Password Lock Market Due to the COVID-19 pandemic, the global Password Lock market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the econo…
ティーメーカーのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Tea Makers Market Due to the COVID-19 pandemic, the global Tea Makers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic ch…